(Q33995617)

30 July 2017

title

Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR. (English)

1 reference

30 July 2017

Robert J Wagner

1

1 reference

30 July 2017

Kathleen A Martin

series ordinal

2

1 reference

30 July 2017

Richard J Powell

series ordinal

3

1 reference

30 July 2017

Eva M Rzucidlo

series ordinal

4

1 reference

30 July 2017

publication date

7 April 2010

1 reference

American Journal of Physiology - Cell Physiology

30 July 2017

published in

1 reference

30 July 2017

volume

299

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

C119-27

1 reference

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Localization of Rheb to the endomembrane is critical for its signaling function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Growing roles for the mTOR pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Rheb binds and regulates the mTOR kinase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Coordinate regulation of translation by the PI 3-kinase and mTOR pathways

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Regulation of translation initiation by FRAP/mTOR

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Enzymology and biology of CaaX protein prenylation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

A simplified system for generating recombinant adenoviruses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Protein prenylation: molecular mechanisms and functional consequences

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Regulation of differentiation of vascular smooth muscle cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Pilot trial of oral rapamycin for recalcitrant restenosis

5 July 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

A comparison of six statins on the development of intimal hyperplasia in a human vein culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00429.2009

Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial)

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904260

Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20375271

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1152/AJPCELL.00429.2009

1 reference

30 July 2017

1 reference

30 July 2017

1 reference